The following article appeared on December 22, 2025 on US REPORTER By: William Jones In Miami’s pulsating legal arena, where the tropical sun burns as fiercely as the battles in its courthouses, Gregg Goldfarb has spent over three decades wielding his legal expertise like a scalpel, slicing through mountains of documents to uncover the truth. […]

The following article appeared on November 25, 2025 on LAW.COM A pivotal federal dismissal in Martinez v. Kraft Heinz spotlights the evidentiary challenges in ultra-processed food (UPF) lawsuits-especially in connecting specific product exposure to harm. As regulators and attorneys step up scrutiny, mass tort strategies are evolving, with insights from leading expert Dr. Marion Nestle. […]

The following article appeared on November 5, 2025, on Bloomberg Law Across the US, school districts are banding together, and parents are joining mass lawsuits in federal and state courts, looking to hold accountable social media companies whose design choices have made platforms central to everyday teenage life. At a recent education law conference in Sacramento, Calif., […]

The following article appeared on July 11, 2025 on Bloomberg Law.   While the Federal Trade Commission’s lawsuit against pharmacy benefit manager giants is paused by a temporary stay, lawsuits from state attorneys general and private plaintiffs offer prime opportunities for attorneys to hold pharmacy benefit managers accountable. State lawsuits are rewriting the rules, demanding agile litigation […]

The following article appeared on February 21, 2025 on Law360 UK. The Rise of GLP-1 Agonists The rapid ascent of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) — such as Novo Nordisk’s Ozempic and Wegovy, and Eli Lilly & Co.’s Mounjaro and Zepbound — has revolutionized diabetes management and weight loss. However, this surge has triggered […]